Finance

Lists
Why is HUMA down २.८६%?
Dive Deeper
HUMA:NASDAQ
Humacyte Inc
US$ ०.५०
-२.८६%
(-०.०१५) 1D
US$ ०.५१
+१.३७% (+०.००६९)
Pre-market
Closed: अक्टोबर १, १६:००:०१ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HUMA...
Open
US$ ०.५२
High
US$ ०.५३
Low
US$ ०.५०
Mkt. cap
१३.९१ करोड
Avg. vol.
५४.५७ लाख
Volume
७.५५ हजार
52-wk high
US$ २.५५
52-wk low
US$ ०.५०
EPS
-US$ ०.४९
Beta
२.४५
Shares outstanding
२७.७८ करोड
No. of employees
१८४
Open
US$ ०.५२
High
US$ ०.५३
Low
US$ ०.५०
Mkt. cap
१३.९१ करोड
Avg. vol.
५४.५७ लाख
Volume
७.५५ हजार
52-wk high
US$ २.५५
52-wk low
US$ ०.५०
EPS
-US$ ०.४९
Beta
२.४५
Shares outstanding
२७.७८ करोड
No. of employees
१८४
News stories
From web sources and news partners
About Humacyte Inc
CEOLaura Niklason
Employees१८४
Founded२००४ जनवरी १
Headquarters-
Sector-
Websitehumacyte.com
Analyst ratings
Based on 4 analysts giving stock ratings to HUMA in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for HUMA in the last 3 months.
Highest
Current US$ ०.५०
US$ ४.०० (+६९५.३९%)
Average
US$ २.०६ (+३०९.६२%)
Lowest
US$ १.०० (+९८.८५%)
Analyst
Recommendation
Action
Price target
Projected
Date
Swayampakula Ramakanth
H.C. Wainwright
Buy
Reiterated
US$ ४.००
+६९५.४%
09/21/2026
Josh Jennings
TD Cowen
Buy
Maintained
US$ १.२५
+१४८.६%
08/19/2026
Allison Bratzel
Piper Sandler
Hold
Maintained
US$ १.००
+९८.८%
08/17/2026
Ryan Zimmerman
BTIG
Buy
Maintained
US$ २.००
+२९७.७%
07/28/2026
Bruce Jackson
Benchmark Co.
Buy
Maintained
US$ २.००
+२९७.७%
06/01/2026
Matt Miksic
Barclays
Buy
Reiterated
US$ १.५०
+१९८.३%
05/13/2026
Last report
२०२६ अगस्ट १२
Fiscal period
Q2 2026
EPS / Est. (USD)
-US$ ०.१६ / -US$ ०.१०
-५४.८४%miss
Revenue / Est. (USD)
४.०६ लाख / ११.१३ लाख
-६३.५२%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
७.५३ लाख
४.६७ लाख
४.९५ लाख
४.०६ लाख
Cost of goods sold
१.७५ करोड
२.३७ करोड
२.०९ करोड
१.९४ करोड
Cost of revenue
१.७५ करोड
२.३७ करोड
२.०९ करोड
१.९४ करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
७६.१० लाख
७६.१६ लाख
७८.३० लाख
८०.२७ लाख
Operating expense
७६.१० लाख
७६.१६ लाख
७८.३० लाख
८०.२७ लाख
Total operating expenses
२.५१ करोड
३.१३ करोड
२.८७ करोड
२.७४ करोड
Operating income
-२.४४ करोड
-३.०८ करोड
-२.८२ करोड
-२.७० करोड
Other non operating income
४०.०९ लाख
२.०६ करोड
८५.२५ लाख
-५१.५५ लाख
EBT including unusual items
-१.७५ करोड
-२.४८ करोड
-१.७६ करोड
-३.६८ करोड
EBT excluding unusual items
-२.२४ करोड
-१.२९ करोड
-२.१७ करोड
-३.४१ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-१.७५ करोड
-२.४८ करोड
-१.७६ करोड
-३.६८ करोड
Net profit margin
-२,३२५.३७%
-५,३११.३५%
-३,५५९.३९%
-९,०६४.५३%
Earnings per share
-०.११
-०.१३
-०.०९
-०.१६
Interest and investment income
५.९० लाख
५.०३ लाख
३.३० लाख
३.८८ लाख
Interest expense
-२६.१२ लाख
-३०.९३ लाख
-२२.७१ लाख
-२३.२१ लाख
Net interest expenses
-२०.२२ लाख
-२५.९० लाख
-१९.४१ लाख
-१९.३३ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२.२५ करोड
-२.९० करोड
-२.६४ करोड
-२.५२ करोड
Gain or loss from assets sale
-
५.०० हजार
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू